Fibrin sealant use for minimising peri-operative allogeneic blood transfusion
Editorial Group: Cochrane Injuries Group
Published Online: 20 JAN 2003
Assessed as up-to-date: 11 MAR 2008
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Carless PA, Henry DA, Anthony DM. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD004171. DOI: 10.1002/14651858.CD004171.
- Publication Status: Edited (no change to conclusions)
- Published Online: 20 JAN 2003
This article has been cited by:
- 1Fibrin sealants or cell saver eliminate the need for autologous blood donation in anemic patients undergoing primary total knee arthroplasty, Archives of Orthopaedic and Trauma Surgery, 2014, 134, 1, 53, , , , ,
- 2Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty, Archives of Orthopaedic and Trauma Surgery, 2012, 132, 8, 1147, , , , ,